Efficacy of ponatinib prior to and after allogeneic hematopoietic stem cell transplantation in an adolescent with chronic myeloid leukemia in blast phase

被引：3

作者：

Lee, Jae Wook ^{[1
]}

Yoo, Jae Won ^{[1
]}

Kim, Seongkoo ^{[1
]}

Jang, Pil-Sang ^{[1
]}

Chung, Nack-Gyun ^{[1
]}

Cho, Bin ^{[1
]}

机构：

[1] Catholic Univ Korea, Div Hematol & Oncol, Dept Pediat, Coll Med, Seoul, South Korea

来源：

BLOOD RESEARCH | 2021年 / 56卷 / 04期

关键词：

IMATINIB; MUTATION; THERAPY; CHILD;

D O I：

10.5045/br.2021.2021104

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：342 / 345

页数：4

共 15 条

[1] The remarkable response to ponatinib therapy in a child with blastic phase of chronic myeloid leukemia [J].

Aksu, Tekin ;

Unal, Sule ;

Gurmuk, Fatma .

TURKISH JOURNAL OF PEDIATRICS, 2020, 62 (03) :479-481

[2] Ponatinib efficacy and safety in Philadelphia chromosome-positive leukemia: final 5-year results of the phase 2 PACE trial [J].

Cortes, Jorge E. ;

Kim, Dong-Wook ;

Pinilla-Ibarz, Javier ;

le Coutre, Philipp D. ;

Paquette, Ronald ;

Chuah, Charles ;

Nicolini, Franck E. ;

Apperley, Jane F. ;

Khoury, H. Jean ;

Talpaz, Moshe ;

DeAngelo, Daniel J. ;

Abruzzese, Elisabetta ;

Rea, Delphine ;

Baccarani, Michele ;

Mueller, Martin C. ;

Gambacorti-Passerini, Carlo ;

Lustgarten, Stephanie ;

Rivera, Victor M. ;

Haluska, Frank G. ;

Guilhot, Francois ;

Deininger, Michael W. ;

Hochhaus, Andreas ;

Hughes, Timothy P. ;

Shah, Neil P. ;

Kantarjian, Hagop M. .

BLOOD, 2018, 132 (04) :393-404

[3] Discontinuation of imatinib in children with chronic myeloid leukaemia in sustained deep molecular remission: results of the STOP IMAPED study [J].

de Bruijn, Clara M. A. ;

Millot, Frederic ;

Suttorp, Meinolf ;

Borisevich, Marina ;

Brons, Paul ;

Lausen, Birgitte ;

de Bont, Eveline S. J. M. .

BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 (04) :718-724

[4] Does Post-Transplant Maintenance Therapy With Tyrosine Kinase Inhibitors. Improve Outcomes of Patients With High-Risk Philadelphia Chromosome-Positive Leukemia? [J].

DeFilip, Zachariah ;

Langston, Amelia A. ;

Chen, Zhengjia ;

Zhang, Chao ;

Arellano, Martha L. ;

El Rassi, Fuad ;

Flowers, Christopher R. ;

Kota, Vamsi K. ;

Al-Kadhimi, Zaid ;

Veldman, Rachel ;

Jillella, Anand P. ;

Lonial, Sagar ;

Waller, Edmund K. ;

Khoury, Hanna J. .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2016, 16 (08) :466-471

[5] Impact of dose intensity of ponatinib on selected adverse events: Multivariate analyses from a pooled population of clinical trial patients [J].

Dorer, David J. ;

Knickerbocker, Ronald K. ;

Baccarani, Michele ;

Cortes, Jorge E. ;

Hochhaus, Andreas ;

Talpaz, Moshe ;

Haluska, Frank G. .

LEUKEMIA RESEARCH, 2016, 48 :84-91

[6] Ponatinib use in two pediatric patients with relapsed Ph plus ALL with ABL1 kinase domain mutations [J].

Gruner, Stephanie E. ;

Sayeed, Hadi ;

Suarez-Ferguson, Lizmery ;

Perez, Cintia ;

Rouce, Rayne ;

Fisher, Kevin E. ;

Rau, Rachel E. .

PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2019, 36 (08) :514-519

[7] Sustained complete molecular remissions after treatment with imatinib-mesylate in patients with failure after allogeneic stem cell transplantation for chronic myelogenous leukemia:: Results of a prospective phase II open-label multicenter study [J].

Hess, G ;

Bunjes, D ;

Siegert, W ;

Schwerdtfeger, R ;

Ledderose, G ;

Wassmann, B ;

Kobbe, G ;

Bornhäuser, M ;

Hochhaus, A ;

Ullmann, AJ ;

Kindler, T ;

Hans, U ;

Gschaidmeier, H ;

Huber, C ;

Fischer, T .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (30) :7583-7593

[8] Ponatinib In Heavily Pretreated Patients With Chronic Phase Chronic Myeloid Leukemia (CP-CML): Management Of Adverse Events (AEs) [J].

Le Coutre, Philipp D. ;

Kim, Dong-Wook ;

Pinilla-Ibarz, Javier ;

Paquette, Ronald ;

Chuah, Charles ;

Nicolini, Franck E. ;

Apperley, Jane F. ;

Khoury, H. Jean ;

Talpaz, Moshe ;

Dipersio, John F. ;

DeAngelo, Daniel J. ;

Abruzzese, Elisabetta ;

Rea, Delphine ;

Baccarani, Michele ;

Muller, Martin C. ;

Gambacorti-Passerini, Carlo ;

Lustgarten, Stephanie ;

Yanase, Kumiko ;

Turner, Christopher D. ;

Haluska, Frank G. ;

Guilhot, Francois ;

Deininger, Michael W. ;

Hochhaus, Andreas ;

Hughes, Timothy P. ;

Goldman, John M. ;

Shah, Neil P. ;

Kantarjian, Hagop M. ;

Cortes, Jorge E. .

BLOOD, 2013, 122 (21)

[9] Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial [J].

Mahon, Francois-Xavier ;

Rea, Delphine ;

Guilhot, Joelle ;

Guilhot, Francois ;

Huguet, Francoise ;

Nicolini, Franck ;

Legros, Laurence ;

Charbonnier, Aude ;

Guerci, Agnes ;

Varet, Bruno ;

Etienne, Gabriel ;

Reiffers, Josy ;

Rousselot, Philippe .

LANCET ONCOLOGY, 2010, 11 (11) :1029-1035

[10] Ponatinib in childhood Philadelphia chromosome-positive leukaemias: an international registry of childhood chronic myeloid leukaemia study [J].

Millot, Frederic ;

Suttorp, Meinolf ;

Versluys, Anne B. ;

Kalwak, Krzysztof ;

Nelken, Brigitte ;

Ducassou, Stephane ;

Bertrand, Yves ;

Baruchel, Andre .

EUROPEAN JOURNAL OF CANCER, 2020, 136 :107-112

← 1 2 →